BioCentury
ARTICLE | Clinical News

Jetrea ocriplasmin: Phase II data

April 6, 2015 7:00 AM UTC

Top-line data from the double-blind, U.S. Phase II OASIS trial in about 220 patients with symptomatic VMA showed that a single 125 ug intravitreal injection of Jetrea met the primary endpoint of a gr...